16 April 2018

Contents

Editorial

• 16 April 2018: vol 19 no 7: CROI 2018 part 3

In memory

• In Memory: Professor David Cooper

Conference reports

• CROI 2018: third reports

• No increased risk of IRIS in people with low CD4 counts receiving raltegravir in the REALITY trial

• Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated

• Efavirenz might decrease effectiveness of the vaginal contraceptive ring

• Switch to TAF appears safe and effective in adolescents: similar PK to adults

• Doubling raltegravir dose could overcome interaction with rifampicin in children aged 2 to 6

• Twice-daily bictegravir does not overcome drug interaction with rifampicin

• Reducing risk of myocardial infarction (MI) in HIV positive people

• M184V mutation associated with increased risk of viral blip but not viral failure with 3TC-based dual therapy

HIV prevention and transmission

• PrEP engagement workshops

On the web

• Legal Aide – an app if arrested for personal drug possession

• IAS reviews

• TAGline Spring 2018

PDFs

• 16 April 2018: vol 19 no 7